BIOC - Long Shot or Undervalued AI Play?

It's always a gamble trying to pick the small caps that'll catch an AI tailwind. Looking at $BIOC, currently sitting at $0.4349, I'd say there's about a 20% chance it sees a significant sustained jump above $0.60 by Q3 end. The reasoning? If any of their less-discussed AI-driven biotech research gets a sniff of real progress or a strategic partnership, the market cap is so small that even a whisper could ignite it. Otherwise, it's a slow grind, if not a deeper slide. Not advice, just observing the high-risk, high-reward nature of these fringe plays.